These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33117971)

  • 21. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
    Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis.
    Lee JS; Lim TS; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Lee HW; Lee JI; Kim JK; Min IK; Kim BK
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment.
    Gokcen P; Guzelbulut F; Adali G; Degirmenci Salturk AG; Ozturk O; Bahadir O; Kanatsiz E; Kiyak M; Ozdil K; Doganay HL
    World J Gastroenterol; 2022 Feb; 28(6):665-674. PubMed ID: 35317422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.
    Flemming JA; Yang JD; Vittinghoff E; Kim WR; Terrault NA
    Cancer; 2014 Nov; 120(22):3485-93. PubMed ID: 25042049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection.
    Innes H; Jepsen P; McDonald S; Dillon J; Hamill V; Yeung A; Benselin J; Went A; Fraser A; Bathgate A; Ansari MA; Barclay ST; Goldberg D; Hayes PC; Johnson P; Barnes E; Irving W; Hutchinson S; Guha IN
    JHEP Rep; 2021 Dec; 3(6):100384. PubMed ID: 34805817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study.
    Zhang H; Zhu J; Xi L; Xu C; Wu A
    World J Surg Oncol; 2019 Apr; 17(1):75. PubMed ID: 31039803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study.
    Mao HD; Zheng SQ; Yang SH; Huang ZY; Xue Y; Zhou M
    PeerJ; 2023; 11():e15014. PubMed ID: 36992940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of acknowledged hepatocellular carcinoma risk scores in high-risk hepatitis C patients with sustained virological response.
    Qiu L; Xu S; Qiu Y; Liu Y; Zhang J
    J Viral Hepat; 2023 Jun; 30(6):559-566. PubMed ID: 36890735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation.
    Wu S; Zeng N; Sun F; Zhou J; Wu X; Sun Y; Wang B; Zhan S; Kong Y; Jia J; You H; Yang HI
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2499-2513. PubMed ID: 33667678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinoma.
    Chon HY; Lee HA; Suh SJ; Lee JI; Kim BS; Kim IH; Lee CH; Jang BK; Lee HW; Hwang JS; Lee CH; Lee JW; Yu JH; Seo YS; Yim HJ; Kim SU;
    Aliment Pharmacol Ther; 2021 Apr; 53(8):919-927. PubMed ID: 33465253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection.
    Ferreira da Silva AC; Cunha-Silva M; Sevá-Pereira T; Mazo DF
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals.
    Shi K; Li P; Zhang Q; Zhang Y; Bi Y; Zeng X; Wang X
    Front Oncol; 2023; 13():1128062. PubMed ID: 36874109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
    Yang H; Bae SH; Nam H; Lee HL; Lee SW; Yoo SH; Song MJ; Kwon JH; Nam SW; Choi JY; Yoon SK; Jang JW
    J Hepatol; 2022 Sep; 77(3):632-641. PubMed ID: 35398462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Nam H; Lee SW; Kwon JH; Lee HL; Yoo SH; Kim HY; Song DS; Sung PS; Chang UI; Kim CW; Nam SW; Bae SH; Choi JY; Yoon SK; Yang JM; Han NI; Jang JW
    Am J Gastroenterol; 2021 Aug; 116(8):1657-1666. PubMed ID: 33734114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.
    Lee HW; Ahn SH
    World J Gastroenterol; 2016 Oct; 22(37):8314-8321. PubMed ID: 27729738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy.
    Lee JS; Lee HW; Lim TS; Shin HJ; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals.
    Ji JH; Park SY; Son WJ; Shin HJ; Lee H; Lee HW; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
    J Viral Hepat; 2021 Jun; 28(6):951-958. PubMed ID: 33763928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Liver Stiffness-Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma.
    Lin H; Li G; Delamarre A; Ahn SH; Zhang X; Kim BK; Liang LY; Lee HW; Wong GL; Yuen PC; Chan HL; Chan SL; Wong VW; de Lédinghen V; Kim SU; Yip TC
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):602-610.e7. PubMed ID: 37993034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.